Business

Eli Lilly and Quantum IPO

Updated 2026-05-26 12:05 UTC 2 sources Neutral

Eli Lilly is planning significant vaccine deals worth nearly $4 billion. Meanwhile, quantum computing company Quantinuum prepares for its initial public offering with a potential valuation of over $13 billion.

Coverage timeline — 2 articles

MarketWatch

This new quantum stock could debut with a valuation of nearly $13 billion

Quantinuum sets terms for its IPO, in which the quantum computing company looks to raise up to $1 billion.

2026-05-26 11:47 UTC

CNBC

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

2026-05-26 11:50 UTC